ILD Center Media

In the lab of Erica Herzog, MD, PhD, scientists are working to cure pulmonary fibrosis, researching the condition's underlying mechanisms to inform approaches for prevention and treatment.

A new Yale School of Medicine study points to progressive stiffening of the pulmonary artery, the main vessel supplying blood to the lungs, as a potential explanation for some of the age-related declines in heart and lung function.

Scientists created a cellular atlas of the lungs to pinpoint cells especially vulnerable to aging. They could be targets for preventing acute and chronic lung diseases.

People diagnosed with chronic obstructive pulmonary disease often experience markedly different symptoms, disease trajectories, and responses to treatment. To better understand this variability, a new study from researchers at Yale School of Medicine used single-cell sequencing technology alongside complementary spatial transcriptomic and proteomic analyses to examine lung tissue from people with COPD in unprecedented detail.

A new review aims to help clinicians better recognize subtle signs of pneumonitis before they escalate.

For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there.

When Naftali Kaminski, MD, was recruited to Yale in 2013 as section chief of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM) he planned to lead it for 10 years. Now, coming up on his thirteenth year, he is stepping down at the end of June 2026.

Each year, the American College of Chest Physicians (CHEST) honors the clinicians, researchers, and educators shaping the future of chest medicine. Among this year’s distinguished honorees are several faculty members from the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine (Yale-PCCSM), recognized for their leadership, innovation, and dedication to the field.

A new paper from Yale School of Medicine researchers suggests that variants of uncertain significance—DNA changes that scientists can detect but, at this time, lack enough evidence to classify as harmful or harmless—may offer important clinical insights that deserve closer attention.